Ancient herbal mix gets a modern test for Crohn's
NCT ID NCT03992469
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-phase trial is testing whether an oral herbal formula called E-B-FAHF-2 is safe and tolerable for people with mild-to-moderate Crohn's disease. Only 7 adults will take either the herbal capsule or a placebo for a short time. The goal is to see if it reduces inflammation and helps maintain remission, with fewer pills needed than earlier versions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
E-B-FAHF-2 (a concentrated herbal formula)
What this could lead to
If it works, this could point toward a new treatment option for mild-to-moderate Crohn's disease that is easier to take than current therapies.
What could go wrong
This is a very early, small Phase 1 trial with only 7 participants, so results may not apply widely. The herbal formula may not prove effective or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States